← All organizations

Equillium

For profitWebsite ↗

Also known as: Equillium | Equillium, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 31, 2022

Timeline

2010s

Jun 1, 2017
Equillium— Founded

2020s

Feb 16, 2022
Bioniz Therapeutics— Acquired
Sep 6, 2022
Metacrine, Inc.— Acquired

Drugs by trial phase (7 distinct, 12 trials)

Phase 3 (1 own, 0 via acquisition)

itolizumab

Phase 2 (1 own, 5 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (9)

NCT05589610Lead sponsorPhase 2Oct 31, 2022
NCT05263999Lead sponsorPhase 3Apr 29, 2022
NCT05263999OfficialPhase 3Apr 29, 2022
NCT04605926Study directorPhase 3Nov 30, 2020
NCT04605926Lead sponsorPhase 3Nov 30, 2020
NCT04128579Lead sponsorPhase 1Oct 1, 2019
NCT03763318Lead sponsorPhase 1/Phase 2Jun 30, 2019
NCT03763318Study directorPhase 1/Phase 2Jun 30, 2019
NCT04007198Lead sponsorPhase 1Jun 20, 2019

Details

Founded: La Jolla, CA, US Jun 1, 2017
Last known activity: Oct 31, 2022